Cover Image

Evaluation of the Antitumor Activity of Dacomitinib in Models of Human Bladder Cancer

Abstract Members of the human epidermal growth factor receptor (HER) family play a significant role in bladder cancer progression and may underlie the development of chemotherapy resistance. Dacomitinib is an irreversible tyrosine kinase inhibitor with structural specificity for the catalytic domain...

Full description

Saved in:

Bibliographic Details
Main Authors:	Petros D. Grivas (Author), Kathleen C. Day (Author), Andreas Karatsinides (Author), Alyssa Paul (Author), Nazia Shakir (Author), Iya Owainati (Author), Monica Liebert (Author), Lakshmi P. Kunju (Author), Dafydd Thomas (Author), Maha Hussain (Author), Mark L. Day (Author)
Format:	Book
Published:	BMC, 2013-10-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Effects of dacomitinib on the pharmacokinetics of poziotinib in vivo and in vitro
by: Weiping Ji, et al.
Published: (2021)

Effects of H2-Receptor Antagonists on the Exposure of Dacomitinib
by: Jian Liu, et al.
Published: (2024)

Tumor growth inhibition modeling to support the starting dose for dacomitinib
by: Luke K. Fostvedt, et al.
Published: (2022)

Clinical evaluation of dacomitinib for the treatment of metastatic non-small cell lung cancer (NSCLC): current perspectives
by: Lavacchi D, et al.
Published: (2019)

Pharmacokinetic Models to Characterize the Absorption Phase and the Influence of a Proton Pump Inhibitor on the Overall Exposure of Dacomitinib
by: Ana Ruiz-Garcia, et al.
Published: (2020)

Sulforaphane and bladder cancer: a potential novel antitumor compound
by: Mingshun Zuo, et al.
Published: (2023)

Dacomitinib in lung cancer: a “lost generation” EGFR tyrosine-kinase inhibitor from a bygone era?
by: Ou SH, et al.
Published: (2015)

Bioequivalence study of dacomitinib and Vizimpro® in healthy Chinese volunteers under fasting and fed conditions: A randomized, open‐label, single‐dose, crossover trial
by: Xiaojia Yang, et al.
Published: (2023)

Antitumor Activities of Aqueous Cinnamon Extract on 5637 Cell Line of Bladder Cancer through Glycolytic Pathway
by: Zeynab Aminzadeh, et al.
Published: (2022)

Pathogenesis of overactive bladder and surgical treatment according to the Integral Theory Paradigm
by: Peter Petros
Published: (2021)

Antitumor Activity of Auger Electron Emitter 111In Delivered by Modular Nanotransporter for Treatment of Bladder Cancer With EGFR Overexpression
by: Andrey A. Rosenkranz, et al.
Published: (2018)

Metallothionein 2A with Antioxidant and Antitumor Activity Is Upregulated by Caffeic Acid Phenethyl Ester in Human Bladder Carcinoma Cells
by: Hsin-Ching Sung, et al.
Published: (2022)

Dacomitinib for Advanced Non-small Cell Lung Cancer Patients Harboring Major Uncommon EGFR Alterations: A Dual-Center, Single-Arm, Ambispective Cohort Study in China
by: Hong-Shuai Li, et al.
Published: (2022)

Is Routine Histopathology Of Gall Bladder After Laparoscopic Cholecystectomy Needed?: A Local Perspective
by: Ali Mohammad Khatri, et al.
Published: (2024)

Cell-penetrating peptide conjugates of gambogic acid enhance the antitumor effect on human bladder cancer EJ cells through ROS-mediated apoptosis
by: Lyu L, et al.
Published: (2018)

The novel antitumor compound clinopodiside A induces cytotoxicity via autophagy mediated by the signaling of BLK and RasGRP2 in T24 bladder cancer cells
by: Rong Sheng Zhou, et al.
Published: (2022)

Vinflunine in the treatment of bladder cancer
by: Mark Bachner, et al.
Published: (2008)

Dicoumarol: from chemistry to antitumor benefits
by: Vera L. M. Silva, et al.
Published: (2022)

IMPLEMENTATION OF THE SKIP LIST DATA STRUCTURE WITH IT'S UPDATE OPERATIONS
by: Maha shakir Ibrahim
Published: (2019)

Commentary: Impact of Fecal Calprotectin Measurement on Decision-Making in Children with Inflammatory Bowel Disease
by: Andrew S. Day, et al.
Published: (2017)

Bladder diverticulum/fistula after previous bladder cystectomy
by: Shengnan Liu, et al.
Published: (2022)

Creating a community advisory board for pediatric bladder health
by: Emily Teehan, et al.
Published: (2024)

Antitumoral Properties of Natural Products
Published: (2020)

Chiral Flavonoids as Antitumor Agents
by: Cláudia Pinto, et al.
Published: (2021)

Epigenetic regulation of MIR145 core promoter controls miR-143/145 cluster in bladder cancer progression and treatment outcome
by: Katerina-Marina Pilala, et al.
Published: (2022)

Microorganisms Identified in the Maternal Bladder: Discovery of the Maternal Bladder Microbiota
by: Kristin M. Jacobs, et al.
Published: (2017)

Localized amyloidosis of the urinary bladder, clinically masquerading as bladder cancer
by: DeSouza Maria, et al.
Published: (2008)

Overactive bladder
by: Anna Zwierzyńska
Published: (2021)

An Unusual Iatrogenic Injury of Urinary Bladder Following Foley's Catheterization
by: Rumsha Sadaf, et al.
Published: (2024)

Rendering Houses in Ladakh
by: Day, Sophie
Published: (2023)

Backwoods to Border
by: Boatright/Day
Published: (1943)

Rendering Houses in Ladakh
by: Day, Sophie
Published: (2023)

First Person Squared A Study of Co-Authoring in the Academy
by: Day, Kami
Published: (2001)

Mantener el Cambio: Lo que Significa el Desarrollo de Capacidades en la Práctica
by: Christopher Day
Published: (2015)

Introduction to Editorial Board Member: Professor Jennifer L. West
by: Emily S. Day
Published: (2021)

Editorial: Insights in pediatric gastroenterology, hepatology and nutrition: 2022
by: Andrew S. Day
Published: (2023)

A review of the use of Complementary and Alternative medicines by children with Inflammatory Bowel Disease
by: Andrew S Day
Published: (2013)

Paediatric Gastroenterology - challenges great and small
by: Andrew S Day
Published: (2013)

Treatment of Plantar Fasciitis with the Yuan-Luo Point Pair: A Clinical Case Report
by: Jonathan Day
Published: (2019)

Antitumor Activity and Antioxidant Status of Caesalpinia bonducella Against Ehrlich Ascites Carcinoma in Swiss Albino Mice
by: Malaya Gupta, et al.
Published: (2004)